Curaleaf To Enter European Market With US$286 Million Acquisition

Curaleaf Holdings (CSE: CURA) this evening announced that it is making a move into European markets. The US-focused cannabis operator has agreed to acquire that of EMMAC Life Sciences, whom is reportedly the largest vertically integrated independent cannabis firm in Europe.

The acquisition will see Curaleaf pay base consideration of US$286 million, which will see 15% paid in cash, or $42.9 million, while the remainder is to be paid via subordinate voting shares. Contingent consideration of up to $57 million will also be paid in subordinate voting shares and cash at the same ratio.

EMMAC currently has operations across the UK, Germany, Italy, Spain and Portugal, where it currently has cultivation, processing, distribution, and R&D operations. An operational presence is also reportedly in place in several EU nations currently enacting new medical cannabis programs.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The current management team of EMMAC is expected to continue to run the day to day operations of the firm. Plans to expand operations are already underway, with a goal of exceeding ten tons per year of cultivation by 2022 to facilitate further growth in the region.

Notably, the transaction consists of a related party transaction due to Executive Chairman Boris Jordan having a profit interest in the transaction, as well as convertible debentures that represent an 8% interest in the European firm via Measure 8 Ventures.

A total of 16.8 million shares are to be issued in connection with the transaction, representing post-transaction ownership of 3% of Curaleaf. Shares issued will be subject to a lock-up arrangement as well.

The transaction is currently slated to close in the second quarter of 2021, subject to customary conditions and regulatory approval.

Curaleaf Holdings last traded at $20.70 on the CSE.


Information for this briefing was found via Sedar and Curaleaf Holdings. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Curaleaf To Acquire Reef Dispensaries For US$286 Million

It may have been delayed by two years, but it appears that Tryke Companies, whom...

Monday, November 8, 2021, 07:49:53 AM

US Cannabis: Illustrating The Performance Of The Top Four Issuers

The upcoming US election has renewed interest in CSE-listed American cannabis operators, many of which...

Monday, October 26, 2020, 12:30:00 PM

Curaleaf Records $317.1 Million In Q3 2021 Revenue, Net Loss

Curaleaf Holdings (CSE: CURA) this evening reported its third quarter 2021 financial results, posting revenues...

Monday, November 8, 2021, 04:25:03 PM

US Cannabis: Earnings Preview For The Oncoming Fourth Quarter Results

March is turning out to be a busy month in public cannabis, with many of...

Monday, March 8, 2021, 04:10:00 PM

Curaleaf Posts Net Loss Of $377 Million In 2022

Curaleaf Holdings (CSE: CURA) has finally published its fourth quarter financial results for the period...

Tuesday, May 2, 2023, 08:36:47 AM